Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
MUSC Foundation for Research Development et al v. AstraZeneca Pharmaceuticals LP
Case Number:
2:13-cv-02078
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
February 19, 2016
AstraZeneca Ducks Row Over Too-Broad Patent
A South Carolina federal judge freed AstraZeneca Pharmaceuticals LP from a medical school's patent infringement suit Friday over cholesterol drug Crestor, finding a university scientist's patent unenforceable because it was broad enough to be considered a hypothesis rather than an invention.
-
December 09, 2013
AstraZeneca Can't Shake Patent Suit Over Crestor Trials
A South Carolina federal judge refused Friday to dismiss a patent infringement suit AstraZeneca Pharmaceuticals LP faces over a clinical trial of alternative uses for its Crestor cholesterol drug, trimming several claims lodged by the University of South Carolina's medical school but leaving others intact.
-
October 24, 2013
AstraZeneca Says Safe Harbor Dooms Crestor Patent Suit
AstraZeneca Pharmaceuticals LP urged a South Carolina federal judge Wednesday to toss a patent infringement suit facing the drugmaker over a clinical trial for Crestor, saying its actions during the trial were protected by a safe harbor provision and there was no proof the company infringed the patents afterward.
-
August 01, 2013
Med School Slaps AstraZeneca With Crestor Patent Suit
The research division of the University of South Carolina's medical school hit AstraZeneca Pharmaceuticals LP with a patent infringement suit in federal court Thursday, alleging that the drugmaker willfully pilfered its technology in its clinical trial for the drug Crestor.